KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2

Related articles

1. Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination

   This article has 18 authors:

   1. Anass Abbad
   2. Brian Lerman
   3. Jordan Ehrenhaus
   4. Brian Monahan
   5. Gagandeep Singh
   6. Adria Wilson
   7. Stefan Slamanig
   8. Ashley Aracena
   9. Neko Lyttle
   10. Jessica Nardulli
   11. Keith Farrugia
   12. Zain Khalil
   13. Ana Silvia Gonzalez-Reiche
   14. Mia Emilia Sordillo
   15. Weina Sun
   16. Harm van Bakel
   17. Viviana Simon
   18. Florian Krammer

2. Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice

   This article has 13 authors:

   1. Chengcheng Fan
   2. Alexander A. Cohen
   3. Kim-Marie A. Dam
   4. Annie V. Rorick
   5. Ange-Célia I. Priso Fils
   6. Zhi Yang
   7. Priyanthi N. P. Gnanapragasam
   8. Luisa N. Segovia
   9. Kathryn E. Huey-Tubman
   10. Woohyun J. Moon
   11. Paulo J.C. Lin
   12. Pamela J. Bjorkman
   13. Magnus A. G. Hoffmann

3. Assessment of SARS-CoV-2 immune escape using antigenic cartography combined with experimental challenge studies

   This article has 10 authors:

   1. Merel te Marvelde
   2. Anna Mykytyn
   3. Edwin Veldhuis Kroeze
   4. Alexandre Bouffier
   5. Debby Schipper
   6. Petra Van den Doel
   7. Kim Handrejk
   8. Björn Koel
   9. Melanie Rissmann
   10. Bart Haagmans